Structures predicted by homology modelling with Robetta or modelled de-novo with evolutionary constraints using GREMLIN and Rosetta.
Filter list by:
Model | Method | Target | Status | Annotation | Organism | Community |
---|---|---|---|---|---|---|
IPD_10554 | comparative modelling | MygeA.01597.a | target approved | Thymidylate kinase (MG_006) | Mycoplasma genitalium | internal |
IPD_10555 | comparative modelling | MygeA.20157.a | target approved | Putative pre-16S rRNA nuclease (MG_505) | Mycoplasma genitalium | internal |
IPD_10557 | comparative modelling | MygeA.18897.a | target approved | Uridylate kinase (MG_434) | Mycoplasma genitalium | internal |
IPD_10560 | comparative modelling | MygeA.17922.a | target approved | 50S ribosomal protein L2 (MG_154) | Mycoplasma genitalium | internal |
IPD_10561 | comparative modelling | MygeA.20170.a | target approved | 50S ribosomal protein L33 2 | Mycoplasma genitalium | internal |
IPD_10562 | comparative modelling | MygeA.20025.a | target approved | Putative ABC transporter ATP-binding MG390 (MG_390) | Mycoplasma genitalium | internal |
IPD_10563 | comparative modelling | MygeA.20156.a | target approved | 50S ribosomal protein L36 (MG_174) | Mycoplasma genitalium | internal |
IPD_10564 | comparative modelling | MygeA.20077.a | target approved | 50S ribosomal protein L34 (MG_466) | Mycoplasma genitalium | internal |
IPD_10567 | comparative modelling | MygeA.00640.a | target approved | Acetate kinase (MG_357) | Mycoplasma genitalium | internal |
IPD_10569 | comparative modelling | MygeA.18184.a | target approved | Formamidopyrimidine-DNA glycosylase (MG_498) | Mycoplasma genitalium | internal |
IPD_10570 | comparative modelling | MygeA.19994.a | target approved | Uncharacterized protein MG323 (MG_323) | Mycoplasma genitalium | internal |
IPD_10571 | comparative modelling | MygeA.17891.a | target approved | 50S ribosomal protein L5 (MG_163) | Mycoplasma genitalium | internal |
IPD_10572 | comparative modelling | MygeA.19072.a | target approved | 50S ribosomal protein L9 (MG_093) | Mycoplasma genitalium | internal |
IPD_10573 | comparative modelling | MygeA.20179.a | target approved | Transketolase (MG_066) | Mycoplasma genitalium | internal |
IPD_10574 | comparative modelling | MygeA.10014.d | target approved | Oligopeptide transport ATP-binding protein OppD (MG_079) | Mycoplasma genitalium | internal |
IPD_10576 | comparative modelling | MygeA.20152.a | target approved | ribonuclease HIII, putative MG199 | Mycoplasma genitalium | internal |
IPD_15652 | comparative modelling | BewuA.18655.a | in PDB | Spike glycoprotein (S) | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
IPD_15657 | comparative modelling | BewuA.20418.a | selected | ORF7a | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
IPD_15661 | comparative modelling | BewuA.18928.a | selected | orf1ab polyprotein nsp1 | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
IPD_15666 | comparative modelling | BewuA.18928.a | purified | orf1ab polyprotein nsp7 | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
IPD_15667 | comparative modelling | BewuA.18928.a | purified | orf1ab polyprotein nsp8 | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
IPD_15668 | comparative modelling | BewuA.18928.a | purified | orf1ab polyprotein nsp9 | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
IPD_15669 | comparative modelling | BewuA.18928.a | purified | orf1ab polyprotein nsp10 | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
IPD_15670 | comparative modelling | BewuA.18928.a | cloned | orf1ab polyprotein RdRp (RNA-directed RNA polymerase) (nsp12) | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |
IPD_15671 | comparative modelling | BewuA.18928.a | purified | orf1ab polyprotein ExoN (Guanine-N7 methyltransferase) (nsp14) | Betacoronavirus SARS-CoV-2 (2019-nCoV) (COVID-19) | interest |